Asymmetric protonation of glutamate residues drives a preferred transport pathway in EmrE.

Abstract

EmrE is an <i>Escherichia coli</i> multidrug efflux pump and member of the small multidrug resistance (SMR) family that transports drugs as a homodimer by harnessing energy from the proton motive force. SMR family transporters contain a conserved glutamate residue in transmembrane 1 (Glu14 in EmrE) that is required for binding protons and drugs. Yet the mechanism underlying proton-coupled transport by the two glutamate residues in the dimer remains unresolved. Here, we used NMR spectroscopy to determine acid dissociation constants (p<i>K</i>_<i>a</i> ) for wild-type EmrE and heterodimers containing one or two Glu14 residues in the dimer. For wild-type EmrE, we measured chemical shifts of the carboxyl side chain of Glu14 using solid-state NMR in lipid bilayers and obtained unambiguous evidence on the existence of asymmetric protonation states. Subsequent measurements of p<i>K</i>_<i>a</i> values for heterodimers with a single Glu14 residue showed no significant differences from heterodimers with two Glu14 residues, supporting a model where the two Glu14 residues have independent p<i>K</i>_<i>a</i> values and are not electrostatically coupled. These insights support a transport pathway with well-defined protonation states in each monomer of the dimer, including a preferred cytoplasmic-facing state where Glu14 is deprotonated in monomer A and protonated in monomer B under pH conditions in the cytoplasm of <i>E. coli</i> Our findings also lead to a model, hop-free exchange, which proposes how exchangers with conformation-dependent p<i>K</i>_<i>a</i> values reduce proton leakage. This model is relevant to the SMR family and transporters comprised of inverted repeat domains.